Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET Life Science Investing
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite Life Science Investing
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds Biotech Investing
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 at Upcoming Medical Meetings Life Science Investing
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Pharmaceutical Investing
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics Life Science Investing
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology Convergence 2026 Life Science Investing
Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Life Science Investing
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 Life Science Investing
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference Life Science Investing
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
